For sales

📢Highlights from the Week of 9th February – 16th February  in the world of pharma and healthcare! 🗞️👀 

VYUHPHARMA Highlights from the Week of 9th February - 16th February MERCK 百奥泰 BIO-THERA AMGEN FDA approves Merck's KEYTRUDA and KEYTRUDA QLEX for certain patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal carcinoma, who have received one or two prior systemic treatment regimens European Commission grants marketing authorization for Bio-Thera's GOTENFIA, a biosimilar referencing SIMPONI, for the treatment of various types of arthritis European Commission approves Amgen's UPLIZNA for the treatment of adult patients with generalized myasthenia gravis who are anti-AChR and anti-MuSK antibody positive (FDA, Approval) (EU, Approval) (EU, Approval) Pg 1/4 All logos and trademarks remain the intellectual properties of their respective owners
Download

Connect with us

Please fill in the information below, and we'll get back to you.